IL6 and metabolic syndrome: Despite the limitations of meta-analysis, the robust methodology followed in selecting RCTs for inclusion and in completing the evaluation does facilitate the conclusion that berberine use in patients with MetS and related disorders appears to have significantly decreased inflammatory markers, including CRP, TNF-α, and IL-6.